Related Issuers
by Stephen Carter
Jan 26, 2021 7:26 AM ET
Moody's/S&P/Fitch rate Biogroup
EUR1bn 144A/Reg S 2-part - CAB
EUR750m sr sec notes due 2028 (7y) B2/B-/B+ (negative/stable/stable); and Laboratoire Eimer EUR250m sr notes due 2029 (8y) Caa1/CCC/CCC+ (negative/stable/stable). Via JPM+. Fitch also revised the outlook to stable from negative